123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma

SE Sharp, BL Shulkin, MJ Gelfand… - Journal of Nuclear …, 2009 - Soc Nuclear Med
The purpose of this study was to compare the diagnostic utility of 123I-
metaiodobenzylguanidine (123I-MIBG) scintigraphy and 18F-FDG PET in neuroblastoma …

18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis

ND Papathanasiou, MN Gaze, K Sullivan… - Journal of Nuclear …, 2011 - Soc Nuclear Med
The aim of our study was to evaluate prospectively the diagnostic performance and
prognostic significance of 18F-FDG PET/CT in comparison with 123I …

124I-MIBG: a new promising positron-emitting radiopharmaceutical for the evaluation of neuroblastoma

A Cistaro, N Quartuccio, F Caobelli… - Nuclear Medicine …, 2015 - journals.viamedica.pl
Neuroblastoma is the most common extra-cranial solid tumor in pediatric patients. Despite
the established role of 123I-MIBG and 131I-MIBG scintigraphy in this tumor, only limited data …

Neuroblastoma: MIBG imaging and new tracers

T Pfluger, A Piccardo - Seminars in Nuclear Medicine, 2017 - Elsevier
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system, and is
metastatic or otherwise high risk for relapse in nearly 50% of cases, with a long-term survival …

123I-MIBG scintigraphy/SPECT versus 18F-FDG PET in paediatric neuroblastoma

HI Melzer, E Coppenrath, I Schmid, MH Albert… - European journal of …, 2011 - Springer
Purpose To analyse different uptake patterns in 123 I-MIBG scintigraphy/SPECT imaging
and 18 F-FDG PET in paediatric neuroblastoma patients. Methods We compared 23 123 I …

124I-MIBG PET/CT to monitor metastatic disease in children with relapsed neuroblastoma

MS Aboian, S Huang… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The metaiodobenzylguanidine (MIBG) scan is one of the most sensitive noninvasive lesion
detection modalities for neuroblastoma. Unlike 123I-MIBG, 124I-MIBG allows high-resolution …

Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study

A Piccardo, E Lopci, M Conte, A Garaventa… - European journal of …, 2012 - Springer
Purpose 18 F-Dopa positron emission tomography (PET)/CT has proved a valuable tool for
the assessment of neuroendocrine tumours. So far no data are available on 18 F-dopa …

Diagnosis, treatment response, and prognosis: the role of 18F-DOPA PET/CT in children affected by neuroblastoma in comparison with 123I-mIBG scan: the first …

A Piccardo, G Morana, M Puntoni… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Our purpose was to evaluate the diagnostic role of 18F-3, 4-dihydroxyphenylalanine (DOPA)
PET/CT at the time of staging in children with neuroblastoma and to investigate its ability to …

68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy

JE Gains, MD Aldridge, MV Mattoli… - Nuclear Medicine …, 2020 - journals.lww.com
Purpose Iodine-131-labelled meta-iodobenzylguanidine (131 I-mIBG) and lutetium-177-
labelled DOTATATE (177 Lu-DOTATATE) are used for molecular radiotherapy of metastatic …

Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma

MT Parisi, MK Greene, TM Dykes… - Investigative …, 1992 - journals.lww.com
RATIONALE AND OBJECTIVES. Metaiodobenzylguanidine (MIBG) has been shown to be
both sensitive and highly specific for the detection of neuroblastoma. However, controversy …